Multidisciplinary Management of Severe COPD

Launched by VASTRA GOTALAND REGION · Apr 23, 2021

Keywords

ClinConnect Summary

The clinical trial titled "Multidisciplinary Management of Severe COPD" is focused on improving the care and management of patients with Chronic Obstructive Pulmonary Disease (COPD). COPD is a long-term lung condition that makes it hard to breathe and can lead to serious health issues, especially during flare-ups or exacerbations. This study aims to see if a personalized and comprehensive approach—considering not just COPD but also other health problems patients may have—can help reduce hospital visits, improve quality of life, and ultimately save lives over a 5-year period.

To participate in this trial, individuals must be at least 40 years old, be smokers or ex-smokers with a history of worsening breathing problems that required hospitalization, and be willing to sign consent forms. Participants will undergo detailed health assessments and receive tailored care plans that may include dietary advice, exercise programs, and management of other health conditions. Regular follow-up visits will track their progress throughout the study. This trial is important because it seeks to provide better, more coordinated care for those suffering from COPD, which could lead to significant improvements in their overall health and well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Male or female patients, aged ≥40 years.
• • 2. Smokers or ex-smokers (≥10 pack-year).
• • 3. Prior hospitalization because of progressively worsening dyspnea (associated or not with increased cough and sputum, and or sputum purulence), with a clinically suspected diagnosis of exacerbations of COPD that prompt the discharging physician to refer the patient to the COPD Center.
• • 4. Signed informed concent form.
• Exclusion Criteria:
• • 1. Presenting to the hospital for similar symptoms, which are not defined by the clinicians as suspected exacerbations of COPD, because of alternative diagnoses not related to patients with COPD (e.g., chest wall trauma, neurological disorders, sepsis, cancer and anemia).
• • 2. Already enrolled in other studies perceived to interfere with this protocol.
• • 3. In whom spirometry test is contraindicated (e.g., hemoptysis, detached retina, active tuberculosis).
• • 4. Unable to comply with study procedures and follow-ups in the opinion of the Investigator (e.g., other severe diseases with short life expectancy or who make it impossible for the patients to participate into the study, evidence of alcohol or drug abuse, dementia, severe psychiatric disorder).
• • 5. Acute myocardial infarction and unstable angina pectoris or arrhythmias requiring specific cardiology ICU.
• • 6. Diagnosed stroke, dementia, degenerative neurological disorders or psychiatry disorders requiring specialized care.
• • 7. At the discretion of the recruiting clinician would not be able to be considered for the study.